1. Home
  2. KTTA vs MFC Comparison

KTTA vs MFC Comparison

Compare KTTA & MFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KTTA
  • MFC
  • Stock Information
  • Founded
  • KTTA 2020
  • MFC 1887
  • Country
  • KTTA United States
  • MFC Canada
  • Employees
  • KTTA 4
  • MFC N/A
  • Industry
  • KTTA Biotechnology: Pharmaceutical Preparations
  • MFC Life Insurance
  • Sector
  • KTTA Health Care
  • MFC Finance
  • Exchange
  • KTTA Nasdaq
  • MFC Nasdaq
  • Market Cap
  • KTTA 5.5M
  • MFC 51.7B
  • IPO Year
  • KTTA 2021
  • MFC 1999
  • Fundamental
  • Price
  • KTTA $0.72
  • MFC $31.03
  • Analyst Decision
  • KTTA
  • MFC Buy
  • Analyst Count
  • KTTA 0
  • MFC 1
  • Target Price
  • KTTA N/A
  • MFC $49.00
  • AVG Volume (30 Days)
  • KTTA 201.4K
  • MFC 1.8M
  • Earning Date
  • KTTA 11-12-2025
  • MFC 11-05-2025
  • Dividend Yield
  • KTTA N/A
  • MFC 3.93%
  • EPS Growth
  • KTTA N/A
  • MFC 33.03
  • EPS
  • KTTA N/A
  • MFC 2.29
  • Revenue
  • KTTA N/A
  • MFC $22,915,108,577.00
  • Revenue This Year
  • KTTA N/A
  • MFC $34.27
  • Revenue Next Year
  • KTTA N/A
  • MFC $8.25
  • P/E Ratio
  • KTTA N/A
  • MFC $13.61
  • Revenue Growth
  • KTTA N/A
  • MFC 9.72
  • 52 Week Low
  • KTTA $0.65
  • MFC $25.92
  • 52 Week High
  • KTTA $7.50
  • MFC $33.07
  • Technical
  • Relative Strength Index (RSI)
  • KTTA 43.23
  • MFC 50.92
  • Support Level
  • KTTA $0.74
  • MFC $30.49
  • Resistance Level
  • KTTA $0.81
  • MFC $32.35
  • Average True Range (ATR)
  • KTTA 0.06
  • MFC 0.49
  • MACD
  • KTTA -0.01
  • MFC 0.10
  • Stochastic Oscillator
  • KTTA 9.32
  • MFC 38.60

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).

About MFC Manulife Financial Corporation

Manulife Financial is one of the Big Three Canadian life insurers. The firm provides life insurance, annuities, and asset management products to individuals and group customers in Canada, the United States, and Asia. The Canadian business segment contributes approximately 22% of adjusted earnings. The Asia segment operates across 12 countries and contributes around 36% of earnings, with a significant presence in Hong Kong and Singapore. The US business, which primarily operates under the John Hancock brand, contributes about 23% of earnings and is one of the top 20 life insurers in the US. Manulife's global asset and wealth management business contributes approximately 20% of its earnings and had around CAD 1.03 trillion in assets under management and administration as of the end of 2024.

Share on Social Networks: